Blood volume and hemodynamics during treatment of major hemorrhage with Ringer solution, 5% albumin, and 20% albumin: a single-center randomized controlled trial
- PMID: 38317178
- PMCID: PMC10840277
- DOI: 10.1186/s13054-024-04821-6
Blood volume and hemodynamics during treatment of major hemorrhage with Ringer solution, 5% albumin, and 20% albumin: a single-center randomized controlled trial
Abstract
Background: Volume replacement with crystalloid fluid is the conventional treatment of hemorrhage. We challenged whether a standardized amount of 5% or 20% albumin could be a viable option to maintain the blood volume during surgery associated with major hemorrhage. Therefore, the aim of this study was to quantify and compare the plasma volume expansion properties of 5% albumin, 20% albumin, and Ringer-lactate, when infused during major surgery.
Methods: In this single-center randomized controlled trial, fluid replacement therapy to combat hypovolemia during the hemorrhagic phase of cystectomy was randomly allocated in 42 patients to receive either 5% albumin (12 mL/kg) or 20% albumin (3 mL/kg) over 30 min at the beginning of the hemorrhagic phase, both completed by a Ringer-lactate replacing blood loss in a 1:1 ratio, or Ringer-lactate alone to replace blood loss in a 3:1 ratio. Measurements of blood hemoglobin over 5 h were used to estimate the effectiveness of each fluid to expand the blood volume using the following regression equation: blood loss plus blood volume expansion = factor + volume of infused albumin + volume of infused Ringer-lactate.
Results: The median hemorrhage was 848 mL [IQR: 615-1145]. The regression equation showed that the Ringer-lactate solution expanded the plasma volume by 0.18 times the infused volume while the corresponding power of 5% and 20% albumin was 0.74 and 2.09, respectively. The Ringer-lactate only fluid program resulted in slight hypovolemia (mean, - 313 mL). The 5% and 20% albumin programs were more effective in filling the vascular system; this was evidenced by blood volume changes of only + 63 mL and - 44 mL, respectively, by long-lasting plasma volume expansion with median half time of 5.5 h and 4.8 h, respectively, and by an increase in the central venous pressure.
Conclusion: The power to expand the plasma volume was 4 and almost 12 times greater for 5% albumin and 20% albumin than for Ringer-lactate, and the effect was sustained over 5 h. The clinical efficacy of albumin during major hemorrhage was quite similar to previous studies with no hemorrhage.
Trial registration: ClinicalTrials.gov NCT05391607, date of registration May 26, 2022.
Keywords: 20% albumin; 5% albumin; Fluid therapy; Hemorrhage; Plasma volume expansion; Ringer-lactate.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures






Similar articles
-
Detection of hypovolemia by non-invasive hemodynamic monitoring during major surgery using Ringer´s solution, 5% albumin, or 20% albumin as infusion fluid: a post-hoc analysis of a randomized clinical trial.Crit Care. 2025 Mar 23;29(1):132. doi: 10.1186/s13054-025-05357-z. Crit Care. 2025. PMID: 40122881 Free PMC article. Clinical Trial.
-
Intraoperative Intravascular Effect of Lactated Ringer's Solution and Hyperoncotic Albumin During Hemorrhage in Cystectomy Patients.Anesth Analg. 2021 Aug 1;133(2):413-422. doi: 10.1213/ANE.0000000000005173. Anesth Analg. 2021. PMID: 32947291
-
Effect of 4% Albumin Solution vs Ringer Acetate on Major Adverse Events in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass: A Randomized Clinical Trial.JAMA. 2022 Jul 19;328(3):251-258. doi: 10.1001/jama.2022.10461. JAMA. 2022. PMID: 35852528 Free PMC article. Clinical Trial.
-
A meta-analysis of Lactate Ringer's solution versus Normal Saline in the treatment of acute pancreatitis.Gastroenterol Hepatol. 2024 Oct;47(8):876-887. doi: 10.1016/j.gastrohep.2023.12.007. Epub 2023 Dec 13. Gastroenterol Hepatol. 2024. PMID: 38101616 English, Spanish.
-
Plasma disappearance rate of albumin when infused as a 20% solution.Crit Care. 2022 Apr 11;26(1):104. doi: 10.1186/s13054-022-03979-1. Crit Care. 2022. PMID: 35410365 Free PMC article. Review.
Cited by
-
Impact of albumin infusion on prognosis in ICU patients with cirrhosis and AKI: insights from the MIMIC-IV database.Front Pharmacol. 2024 Oct 7;15:1467752. doi: 10.3389/fphar.2024.1467752. eCollection 2024. Front Pharmacol. 2024. PMID: 39434907 Free PMC article.
-
Detection of hypovolemia by non-invasive hemodynamic monitoring during major surgery using Ringer´s solution, 5% albumin, or 20% albumin as infusion fluid: a post-hoc analysis of a randomized clinical trial.Crit Care. 2025 Mar 23;29(1):132. doi: 10.1186/s13054-025-05357-z. Crit Care. 2025. PMID: 40122881 Free PMC article. Clinical Trial.
-
Albumin in Normovolemic Fluid Management for Severe Traumatic Brain Injury: Controversies and Research Gaps.J Clin Med. 2024 Sep 13;13(18):5452. doi: 10.3390/jcm13185452. J Clin Med. 2024. PMID: 39336939 Free PMC article.
References
-
- Hahn RG, Brauer L, Rodhe P, Svensen CH, Prough DS. Isoflurane inhibits compensatory intravascular volume expansion after hemorrhage in sheep. Anesth Analg. 2006;103(2):350–358. doi: 10.1213/01.ane.0000222469.94134.ba. - DOI - PubMed